# Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population

> **NCT04224896** · — · COMPLETED · sponsor: **Hôpital Edouard Herriot** · enrollment: 335 (actual)

## Conditions studied

- FRENCH STUDY

## Interventions

- **DIAGNOSTIC_TEST:** UPPER ENDOSCOPY

## Key facts

- **NCT ID:** NCT04224896
- **Lead sponsor:** Hôpital Edouard Herriot
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03-01
- **Primary completion:** 2011-03-01
- **Final completion:** 2015-12-31
- **Target enrollment:** 335 (ACTUAL)
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04224896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04224896, "Narrow-Band Imaging (NBI) Versus Lugol Chromoendoscopy in the Detection of Oesophagus Squamous Cell Carcinoma in High Risk Population". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04224896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*